5289 View: Overview

Glossary  HistCite Guide

Author(s) Schubert S; Kurreck J Title Ribozyme-and deoxyribozyme-strategies for medical applications Source CURRENT DRUG TARGETS 5 (8): 667-681 Date 2004 NOV Type Journal : Review LCR: 1   NCR: 140   LCS: 1   GCS: 7 Comment   Address Free Univ Berlin, Inst Chem Biochem, D-14195 Berlin, Germany. Reprint Kurreck, J, Free Univ Berlin, Inst Chem Biochem, Thielallee 63, D-14195 Berlin, Germany. E-mail jkurreck@chemie.fu-berlin.de Abstract Ribozymes are catalytically active nucleic acids capable of site-specific cleavage of target mRNAs. They have widely been employed as tools in functional studies and for therapeutic purposes. Different classes of ribozymes distinguished by size and mechanism of action have been discovered in natural systems or obtained by in vitro selection. After art introduction to different types of ribozymes with a special focus on the hammerhead and hairpin ribozyme, major challenges in the process of developing ribozymes for medical purposes will be described in the present review. Subsequently, examples of ribozyme applications in animal models for various diseases including cancer, viral infections, rheumatoid arthritis and cardiovascular diseases will be given. The course of phase I and 11 clinical trials with ribozymes designed to treat patients with virus infections or cancer will be Outlined. Finally, the current significance of ribozymes will be discussed in the light of the emergence of new powerful anti-mRNA strategies, particularly RNA interference (RNAi). CR ADAMS PL, 2004, NATURE, V430, P45 AMADO RG, 1999, HUM GENE THER, V10, P2255 BAI JR, 2002, MOL THER, V6, P770 BARROSODELJESUS A, 2004, METHOD MOL BIOL, V252, P313 BEGER C, 2001, P NATL ACAD SCI USA, V98, P130 BEIGELMAN L, 1995, J BIOL CHEM, V270, P25702 BOWDEN ET, 2004, METHOD MOL BIOL, V252, P179 BRAMLAGE B, 2000, NUCLEIC ACIDS RES, V28, P4059 BREAKER RR, 2000, SCIENCE, V290, P2095 BYUN J, 2003, RNA, V9, P1254 CAIRNS MJ, 1999, NAT BIOTECHNOL, V17, P480 CAIRNS MJ, 2003, NUCLEIC ACIDS RES, V31, P2883 CONATY J, 1999, NUCLEIC ACIDS RES, V27, P2400 COOPER R, 1999, J DEMOCR, V10, P8 CROOKE ST, 2004, ANNU REV MED, V55, P61 DELAPENA M, 2003, EMBO J, V22, P5561 DEYOUNG MB, 1995, BIOCHEMISTRY-US, V34, P15785 DORSETT Y, 2004, NAT REV DRUG DISCOV, V3, P318 DOUDNA JA, 2002, NATURE, V418, P222 DUNN W, 2004, METHOD MOL BIOL, V252, P425 EARNSHAW DJ, 1998, NUCLEIC ACIDS RES, V26, P5551 ECKSTEIN F, 2000, ANTISENSE NUCLEIC A, V10, P117 ECKSTEIN F, 2001, CHEMBIOCHEM, V2, P629 FAHMY RG, 2004, NUCLEIC ACIDS RES, V32, P2281 FERREDAMARE AR, 1998, NATURE, V395, P567 FERREDAMARE AR, 2004, BIOPOLYMERS, V73, P71 FLORY CM, 1996, P NATL ACAD SCI USA, V93, P754 GALBRAITH WM, 1994, ANTISENSE RES DEV, V4, P201 GAUTHEROT I, 2004, BIODRUGS, V18, P37 GEARY RS, 2001, J PHARMACOL EXP THER, V296, P890 GOILA R, 1998, FEBS LETT, V436, P233 GUERRIERTAKADA C, 1983, CELL, V35, P849 GUERRIERTAKADA C, 2000, METHOD ENZYMOL, V313, P442 GUO HT, 2000, SCIENCE, V289, P452 HAMPEL A, 1989, BIOCHEMISTRY-US, V28, P4929 HASELOFF J, 1988, NATURE, V334, P585 HEGG LA, 1995, BIOCHEMISTRY-US, V34, P15813 HERYNK MH, 2003, CANCER RES, V63, P2990 HUDSON AJ, 1999, INT J PHARM, V182, P49 HUGHES MD, 2001, DRUG DISCOV TODAY, V6, P303 IVERSEN PO, 2001, AM J PHYSIOL-HEART C, V281, PH2211 IVERSEN PO, 2002, BLOOD, V99, P4147 JARVIS TC, 1996, J BIOL CHEM, V271, P29107 JEPSEN JS, 2004, OLIGONUCLEOTIDES, V14, P130 JOYCE GF, 2001, METHOD ENZYMOL, V341, P503 KAWAKAMI J, 1996, FEBS LETT, V394, P132 KHACHIGIAN LM, 2002, CURR OPIN MOL THER, V4, P119 KHACHIGIAN LM, 2002, J BIOL CHEM, V277, P22985 KHVOROVA A, 2003, NAT STRUCT BIOL, V10, P708 KLEBBA C, 2000, GENE THER, V7, P408 KORE AR, 1998, NUCLEIC ACIDS RES, V26, P4116 KRUGER K, 1982, CELL, V31, P147 KURRECK J, 2002, J BIOL CHEM, V277, P7099 KURRECK J, 2003, EUR J BIOCHEM, V270, P1628 LAFONTAINE DA, 2002, EMBO J, V21, P2461 LAN N, 1998, SCIENCE, V280, P1593 LEAVITT MC, 1996, GENE THER, V3, P599 LEBEDEVA I, 2001, ANNU REV PHARMACOL, V41, P403 LEE NS, 1999, RNA, V5, P1200 LEVIN AA, 1999, BBA-GENE STRUCT EXPR, V1489, P69 LHUILLIER PJ, 1996, P NATL ACAD SCI USA, V93, P6698 LIEBER A, 1995, MOL CELL BIOL, V15, P540 LIEBER A, 1996, J VIROL, V70, P3153 LILLEY DMJ, 2004, RNA, V10, P151 LIU FY, 1995, GENE DEV, V9, P471 LOWE HC, 2001, CIRC RES, V89, P670 LOWE HC, 2002, THROMB HAEMOSTASIS, V87, P134 LYNGSTADAAS SP, 1995, EMBO J, V14, P5224 MACEJAK DG, 2000, HEPATOLOGY, V31, P769 MICHIENZI A, 2001, METHOD ENZYMOL, V341, P581 MICHIENZI A, 2003, ANN NY ACAD SCI, V1002, P63 MITCHELL A, 2004, NUCLEIC ACIDS RES, V32, P3065 NGOK FK, 2004, METHOD MOL BIOL, V252, P581 NISSEN P, 2000, SCIENCE, V289, P920 NOSRATI M, 2004, CLIN CANCER RES, V10, P4983 OJWANG JO, 1992, P NATL ACAD SCI USA, V89, P10802 OSHIMA K, 2003, CANCER RES, V63, P6809 PAN WH, 2004, MOL THER, V9, P596 PENEDO JC, 2004, RNA, V10, P880 PENNATI M, 2004, CARCINOGENESIS, V25, P1129 PERACCHI A, 2004, REV MED VIROL, V14, P47 PEREZRUIZ M, 1999, J BIOL CHEM, V274, P29376 PHYLACTOU LA, 1998, NAT GENET, V18, P378 PLEY HW, 1994, NATURE, V372, P68 POLLER W, 2004, Z KARDIOL, V93, P171 RAI S, 2004, METHOD MOL BIOL, V252, P413 RICHARDSON MW, 2004, METHOD MOL BIOL, V252, P339 RUPERT PB, 2001, NATURE, V410, P780 RUPERT PB, 2002, SCIENCE, V298, P1421 RUTKAUSKAITE E, 2004, ARTHRITIS RHEUM, V50, P1448 SANDBERG JA, 2000, J CLIN PHARMACOL 2, V40, P1462 SANTIAGO FS, 1999, NAT MED, V5, P1264 SANTORO SW, 1997, P NATL ACAD SCI USA, V94, P4262 SANTORO SW, 1998, BIOCHEMISTRY-US, V37, P13330 SAVILLE BJ, 1990, CELL, V61, P685 SCHEDEL J, 2004, GENE THER, V11, P1040 SCHERR M, 2000, MOL THER, V2, P26 SCHUBERT S, 2003, NUCLEIC ACIDS RES, V31, P5982 SCHUBERT S, 2004, J MOL BIOL, V339, P355 SCOTT DL, 1995, MICROBIOS, V81, P7 SEKSEK O, 2004, METHOD MOL BIOL, V252, P545 SHIH IH, 2002, ANNU REV BIOCHEM, V71, P887 SIOUD M, 2000, J MOL BIOL, V296, P937 SOHAIL M, 2000, ADV DRUG DELIVER REV, V44, P23 STAGEZIMMERMANN TK, 1998, RNA, V4, P875 STEIN CA, 2001, J CLIN INVEST, V108, P641 SULLENGER BA, 1993, SCIENCE, V262, P1566 SULLENGER BA, 2002, NATURE, V418, P252 SUN LQ, 2000, PHARMACOL REV, V52, P325 SUYAMA E, 2003, P NATL ACAD SCI USA, V100, P5616 SUYAMA E, 2004, J BIOL CHEM, V279, P38083 TAKAHASHI H, 2004, FEBS LETT, V560, P69 TANABE T, 2000, NATURE, V406, P473 TANNER NK, 1999, FEMS MICROBIOL REV, V23, P257 TRANG P, 2004, CELL MICROBIOL, V6, P499 TSUKIOKA K, 2002, CARDIOVASC RES, V56, P472 UHLENBECK OC, 1987, NATURE, V328, P596 USMAN N, 2000, J CLIN INVEST, V106, P1197 VESTER B, 2002, J AM CHEM SOC, V124, P13682 WALTER NG, 1998, EMBO J, V17, P2378 WANG LX, 2003, ANTISENSE NUCLEIC A, V13, P169 WARASHINA M, 1999, CHEM BIOL, V6, P237 WARASHINA M, 2001, P NATL ACAD SCI USA, V98, P5572 WEDEKIND JE, 1998, ANNU REV BIOPH BIOM, V27, P475 WELZ R, 2003, ANGEW CHEM INT EDIT, V42, P2424 WILLKOMM DK, 2003, CHEMBIOCHEM, V4, P1041 WILSON TJ, 2002, RNA, V8, P587 WONGSTAAL F, 1998, HUM GENE THER, V9, P2407 WRIGHT L, 2001, CANCER INVEST, V19, P495 WU HN, 1989, P NATL ACAD SCI USA, V86, P1831 WU YP, 1999, HUM GENE THER, V10, P2847 YAMADA O, 1994, GENE THER, V1, P38 YAMAMOTO K, 2000, CIRCULATION, V102, P1308 YU M, 1995, VIROLOGY, V206, P381 ZABOROWSKA Z, 2002, J BIOL CHEM, V277, P40617 ZHANG GS, 2004, J NATL CANCER I, V96, P683 ZHANG L, 2002, CANCER RES, V62, P5463 ZHANG XY, 1999, FEBS LETT, V458, P151 ZHOU TH, 2002, J BIOL CHEM, V277, P30112 ZINNEN SP, 2002, RNA, V8, P214